The Acino Healthcare Group is a Swiss pharmaceutical company headquartered in Midrand, Gauteng. We develop and manufacture quality medicines that add value to our customers and positively impact the lives of patients.
Acino Healthcare Group, formally South Africa’s Litha Healthcare Group, consisting of Litha Pharma, Pharmaplan, Pharmafrica, Goldex and Manta forensic, was acquired by Acino Pharma AG in 2017. This acquisition provided Acino with immediate access to and a strong presence in the Southern African market. Also a key step for Acino, as it helped to strengthen it’s position in the African pharmaceutical landscape and, in turn, make advanced healthcare products and expertise accessible.

Acino Healthcare Group is passionate about its commitment to making quality medicines accessible to all South Africans for a healthier tomorrow.

“With our well-established product pipeline and long-standing relationships with licensing partners we are well positioned to achieve our vision of being one of the top 10 pharmaceutical companies in South Africa.” – John Norman, Regional Director ESA.